Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
|
ID |
|
DeNA Co Ltd
F:D2N
|
JP |
|
B
|
Brady Corp
F:BRV
|
US |
|
Mechel PAO
MOEX:MTLR
|
RU |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
EverFocus Electronics Corp
TWSE:5484
|
TW |
|
S
|
Speco
KOSDAQ:013810
|
KR |
|
P
|
Premier American Uranium Inc
XTSX:PUR
|
CA |
|
Sanlorenzo SpA
MIL:SL
|
IT |
|
B
|
Bank of Nova Scotia
F:BKN
|
CA |
|
Platinum Group Metals Ltd
TSX:PTM
|
CA |
Intrinsic Value
Is DGNS undervalued or overvalued?
See the intrinsic value estimate for Diagnos Laboratorium Utama PT Tbk and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
DGNS looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with DGNS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Diagnos Laboratorium Utama PT Tbk Does
Diagnos Laboratorium Utama PT Tbk is an Indonesian medical laboratory company. It runs diagnostic testing services for hospitals, doctors, clinics, and direct patients, covering routine blood work, disease screening, and other lab exams that help doctors confirm a diagnosis or track treatment.
- Headquarters
- Indonesia ID
- Employees
- 54
- IPO date
- Jan 15, 2021
Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk
The intrinsic value for Diagnos Laboratorium Utama PT Tbk (DGNS) under the Base Case is hidden IDR.
Compared with the current market price of 298 IDR, the stock appears hidden.